Iksuda Therapeutics Ltd.

This early-stage trial is testing a new experimental drug called IKS03 in adults with advanced B-cell non-Hodgkin lymphomas that have returned or stopped responding to standard treatments. The study aims to find the safest and most effective dose by first testing increasing amoun…

This early-stage trial is testing a new targeted cancer drug called IKS014 in people with advanced HER2-positive solid tumors, including breast and stomach cancers. The main goals are to find the highest safe dose and see if the drug can shrink tumors. The study will enroll about…